Literature DB >> 88734

Noncovalent intermolecular crosslinks are produced by bleomycin reaction with duplex DNA.

R S Lloyd, C W Haidle, D L Robberson.   

Abstract

Reaction of covalently closed circular PM2 bacteriophage DNA with the anticancer drug bleomycin produces nicked circular (form II) and linear duplex (form III) DNA [Lloyd, R.S., Haidle, C.W. & Robberson, D.L. (1978) Biochemistry 17, 1890-1896]. As the reaction proceeds, the frequencies of both form II and form III DNA increase and, concomitantly, an increasing fraction of the DNA mass is found to be in crosslinked structures. Approximately 16% of the PM2 DNA mass is found to be crosslinked after 30 min of reaction with bleomycin at 0.5 microgram/ml. The proportion of each form found in any given crosslinked structure is directly related to the concentration of uncrosslinked (monomeric) forms. Multiple sites of crosslinking occur, and these frequently extend over a region of approximately 500 nucleotide pairs. The intermolecular crosslinked bonds are dissociated by extensive dialysis or by the addition of salt at high concentration (0.8 M NaCl), as would be expected if the bonds were noncovalent. Because intramolecular covalent crosslinks between complementary strands are not detected, it is suggested that intermolecular crosslinks are formed by noncovalent association of bleomycin molecules bound to each of the forms of DNA.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 88734      PMCID: PMC383670          DOI: 10.1073/pnas.76.6.2674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  13 in total

1.  A MOLECULAR MECHANISM OF MITOMYCIN ACTION: LINKING OF COMPLEMENTARY DNA STRANDS.

Authors:  V N IYER; W SZYBALSKI
Journal:  Proc Natl Acad Sci U S A       Date:  1963-08       Impact factor: 11.205

2.  "Reversible" DNA.

Authors:  E P GEIDUSCHEK
Journal:  Proc Natl Acad Sci U S A       Date:  1961-07-15       Impact factor: 11.205

3.  Fragmentation of deoxyribonucleic acid by bleomycin.

Authors:  C W Haidle
Journal:  Mol Pharmacol       Date:  1971-11       Impact factor: 4.436

4.  Action of bleomycin on DNA and RNA.

Authors:  W E Müller; Z Yamazaki; H J Breter; R K Zahn
Journal:  Eur J Biochem       Date:  1972-12-18

5.  Release of free bases from deoxyribonucleic acid after reaction with bleomycin.

Authors:  C W Haidle; K K Weiss; M T Kuo
Journal:  Mol Pharmacol       Date:  1972-09       Impact factor: 4.436

6.  Light-induced cross-linking of DNA in the presence of a furocoumarin (psoralen). Studies with phage lambda, Escherichia coli, and mouse leukemia cells.

Authors:  R S Cole
Journal:  Biochim Biophys Acta       Date:  1970-09-17

7.  Structure and synthesis of a lipid-containing bacteriophage. X. Improved techniques for the purification of bacteriophage PM2.

Authors:  M Salditt; S N Braunstein; R D Camerini-Otero; R M Franklin
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

8.  Electron-microscopic visualization of deletion mutations.

Authors:  R W Davis; N Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1968-05       Impact factor: 11.205

9.  DNA double-strand breaks and alkali-labile bonds produced by bleomycin.

Authors:  L F Povirk; W Wübter; W Köhnlein; F Hutchinson
Journal:  Nucleic Acids Res       Date:  1977-10       Impact factor: 16.971

10.  Bleomycin-specific fragmentation of double-stranded DNA.

Authors:  R S Lloyd; C W Haidle; D L Robberson
Journal:  Biochemistry       Date:  1978-05-16       Impact factor: 3.162

View more
  5 in total

1.  Studying the effect of a charged surface on the interaction of bleomycin with DNA using an atomic force microscope.

Authors:  Olivier Piétrement; David Pastré; Fabrice Landousy; Marie-Odile David; Stéphane Fusil; Loïc Hamon; Alain Zozime; Eric Le Cam
Journal:  Eur Biophys J       Date:  2004-11-05       Impact factor: 1.733

2.  Comparison of the response of synchronized HeLa cells to talisomycin and bleomycin.

Authors:  C K Mirabelli; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

3.  cdc9 ligase-defective mutants of Saccharomyces cerevisiae exhibit lowered resistance to lethal effects of bleomycin.

Authors:  C W Moore
Journal:  J Bacteriol       Date:  1982-09       Impact factor: 3.490

4.  Structure-activity relationships involved in the site-specific fragmentation of linear duplex DNAs by talisomycin and bleomycin analogs.

Authors:  C K Mirabelli; C H Huang; A W Prestayko; S T Crooke
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

5.  Expression of the denV gene of bacteriophage T4 cloned in Escherichia coli.

Authors:  R S Lloyd; P C Hanawalt
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.